MiR-221 and 222 also promote metastasis in HCC by targeting Plant homeodomain finger 2 (PHF2), AKT pathway, PTEN, CDK inhibitor p27 and DDIT4 [88,89]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.